Our Products
|
|
Olatec’s pharmaceutical platform is intended to address significant unmet needs relative to the currently available treatments in large and growing markets currently dominated by biologics, NSAIDs and steroids. Based on clinical results and the expected market advantages of dapansutrile, including safety, lower cost and more favorable dosage forms over available treatments (e.g., biologics), dapansutrile has the potential not only to transform and expand these markets, but also to represent a new class of pharmaceuticals for the treatment of inflammatory and other diseases.
|